89Zr-DFO-girentuximab Expanded Access Program (EAP)
Clinical trial NCT06090331 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT06090331
- Sponsor
- Telix Pharmaceuticals (Innovations) Pty Limited
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.